|
| 微小RNA在原发性胆汁性
胆管炎发病机制和诊疗中的作用 |
| Role of microRNA in the pathogenesis, diagnosis and treatment of primary biliary cholangitis |
| |
| DOI：10.3969/j.issn.1007-8134.2022.04.001 |
| 中文关键词: 原发性胆汁性胆管炎 微小RNA 胆汁淤积 诊断 治疗 |
| 英文关键词: primary biliary cholangitis microRNA cholestasis diagnosis treatment |
| 基金项目: |
|
| 摘要点击次数: 271 |
| 全文下载次数: 273 |
| 中文摘要: |
| [摘要]?原发性胆汁性胆管炎（primary biliary cholangitis, PBC）是一种慢性胆汁淤积性肝病，其具体病因尚不明确。研究表明PBC中存在表观遗传异常，尤其是微小RNA（microRNA, miRNA）的改变，miRNA可参与PBC的发病过程，并在诊断、疾病进展、疗效预测中作为潜在靶点发挥生物标志物作用。本文将综述miRNA在PBC机制调控、诊疗中作用的研究进展，为PBC相关miRNA的研究提供思路。 |
| 英文摘要: |
| [Abstract] Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease of unknown etiology. Studies have shown that there are epigenetic abnormalities in PBC, especially the changes of microRNA (miRNA), which can participate in the pathogenesis of PBC and play a marker role as a potential target in diagnosis, disease progression, and efficacy prediction. This article reviewed the progress of miRNAs in PBC mechanism regulation, diagnosis and treatment, and provided ideas for the study of PBC-related miRNAs. |
|
HTML
查看全文
下载PDF阅读器 |
| 关闭 |